每周股票复盘：毕得医药（688073）拟用不超2亿闲资理财

Core Points - Bid Pharma's stock price decreased by 10.07% this week, closing at 64.77 yuan, with a market capitalization of 5.886 billion yuan [1] - The company plans to conduct foreign exchange hedging to mitigate currency fluctuation risks, with a maximum contract value of 600 million yuan [2][4] - Bid Pharma's initial public offering raised approximately 1.335 billion yuan, with plans to use up to 200 million yuan of idle funds for cash management [3][4] Company Announcements - Bid Pharma intends to engage in foreign exchange hedging, with a limit of 600 million yuan for any single trading day [2][4] - The company has approved the use of up to 200 million yuan of idle raised funds for cash management, focusing on low-risk, liquid financial products [3][4]